BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35848787)

  • 1. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
    Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
    Lee JH; Lee J; Yhim HY; Oh D; Bang SM
    J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
    Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
    Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
    Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
    Ku GH; White RH; Chew HK; Harvey DJ; Zhou H; Wun T
    Blood; 2009 Apr; 113(17):3911-7. PubMed ID: 19088376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pichler H; Reismüller B; Steiner M; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Panzer-Grümayer R; Haas OA; Attarbaschi A; Mann G;
    Br J Haematol; 2013 May; 161(4):556-65. PubMed ID: 23480776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
    Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
    Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in children with acute lymphoblastic leukemia in China: a report from the Chinese Children's Cancer Group-ALL-2015.
    Yin M; Wang H; Guan X; Gao J; Yang M; Wang N; Liu T; Tang J; Leung AWK; Zhou F; Wu X; Huang J; Li H; Hu S; Tian X; Jiang H; Cai J; Zhai X; Shen S; Hu Q
    Front Med; 2023 Jun; 17(3):518-526. PubMed ID: 36807106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism After Peripherally Inserted Central Catheters Placement in Children With Acute Leukemia: A Single-center Retrospective Cohort Study.
    Ren Y; Chang L; Zhao B; Zhang X; Wan Y; Zhu X; Zhang H
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e407-e409. PubMed ID: 32427704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation.
    Lauw MN; Van der Holt B; Middeldorp S; Meijers JC; Cornelissen JJ; Biemond BJ
    Thromb Haemost; 2013 Apr; 109(4):633-42. PubMed ID: 23364346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L-ASP: A retrospective analysis with an ASP-based protocol in adult patients with acute lymphoblastic leukaemia.
    Chen R; Atenafu EG; Seki J; Liu X; Chan S; Gupta V; Maze D; Shuh AC; Minden MD; Yee K; Schimmer AD; Sibai H
    Br J Haematol; 2023 May; 201(4):645-652. PubMed ID: 36794878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
    Sibai H; Chen R; Liu X; Falcone U; Schimmer A; Schuh A; Law A; McNamara C; Maze D; Yee K; Minden M; Chan SM; Gupta V; Murphy T; Sakurai N; Atenafu EG; Brandwein JM; Seki JT
    Br J Haematol; 2020 Dec; 191(5):748-754. PubMed ID: 32395867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
    Goyal G; Bhatt VR
    Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
    Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
    Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
    Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
    BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G;
    Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
    Kashanian SM; Holtzman NG; Patzke CL; Cornu J; Duffy A; Koka M; Niyongere S; Duong VH; Baer MR; Apata J; Kamangar F; Emadi A
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):817-826. PubMed ID: 33677674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience.
    Brown MA; Fulkerson DH
    Childs Nerv Syst; 2020 May; 36(5):987-992. PubMed ID: 31691011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.
    Degliuomini M; Cooley V; Mauer E; Gerber LM; Acharya S; Kucine N
    J Thromb Thrombolysis; 2021 Jul; 52(1):209-213. PubMed ID: 33486673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.